STOCK-BASED COMPENSATION (Tables)
|
9 Months Ended |
Sep. 30, 2020 |
|---|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
| SCHEDULE OF STOCK BASED COMPENSATION |
The
following table summarizes stock option-based compensation for the three and nine months ended September 30, 2020 and 2019:
SCHEDULE OF STOCK BASED COMPENSATION
| |
|
For
the three months ended September 30, |
|
|
For
the nine months ended September 30, |
|
| |
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
| Research and development |
|
$ |
765,000 |
|
|
$ |
972,000 |
|
|
$ |
2,380,000 |
|
|
$ |
3,013,000 |
|
| General and administrative |
|
|
484,000 |
|
|
|
854,000 |
|
|
|
1,703,000 |
|
|
|
2,594,000 |
|
| Stock option-based compensation expense
included in operating expense |
|
|
1,249,000 |
|
|
|
1,826,000 |
|
|
|
4,083,000 |
|
|
|
5,607,000 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total stock option-based compensation
expense |
|
|
1,249,000 |
|
|
|
1,826,000 |
|
|
|
4,083,000 |
|
|
|
5,607,000 |
|
| Tax benefit |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Stock option-based
compensation expense, net of tax |
|
$ |
1,249,000 |
|
|
$ |
1,826,000 |
|
|
$ |
4,083,000 |
|
|
$ |
5,607,000 |
|
|
| SCHEDULE OF WEIGHTED-AVERAGE ASSUMPTIONS TO ESTIMATE THE FAIR VALUE OF THE OPTIONS GRANTED |
We
used the following weighted-average assumptions to estimate the fair value of the options granted for the periods indicated:
SCHEDULE OF WEIGHTED-AVERAGE ASSUMPTIONS TO ESTIMATE THE FAIR VALUE OF THE OPTIONS GRANTED
| |
|
For
the three months ended September 30, |
|
|
For
the nine months ended September 30, |
|
| |
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
| Expected volatility |
|
|
110% |
|
|
|
103% |
|
|
|
111% |
|
|
|
108% |
|
| Expected term |
|
|
6.25
years |
|
|
|
6.25
years |
|
|
|
6.25
years |
|
|
|
5.09
years |
|
| Risk-free interest rate |
|
|
0.16% |
|
|
|
1.83% |
|
|
|
0.29% |
|
|
|
2.21% |
|
| Expected dividend yield |
|
|
0% |
|
|
|
0% |
|
|
|
0% |
|
|
|
0% |
|
|
| SCHEDULE OF OPTIONS ACTIVITY |
The
following table summarizes the options granted for the periods indicated:
SCHEDULE OF OPTIONS ACTIVITY
| |
|
For
the three months ended September 30, |
|
|
For
the nine months ended September 30, |
|
| |
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
| Options granted |
|
|
342,100 |
|
|
|
105,600 |
|
|
|
3,415,146 |
|
|
|
1,490,490 |
|
| Weighted-average: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
$ |
3.08 |
|
|
$ |
2.58 |
|
|
$ |
2.38 |
|
|
$ |
6.53 |
|
| Grant date fair value |
|
$ |
2.56 |
|
|
$ |
2.09 |
|
|
$ |
1.99 |
|
|
$ |
5.14 |
|
|
| Restricted Stock [Member] |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
| SCHEDULE OF STOCK BASED COMPENSATION |
The
following table summarizes restricted common stock compensation expense for the three and nine months ended September 30, 2020
and 2019:
SCHEDULE OF STOCK BASED COMPENSATION
| |
|
For
the three months ended September 30, |
|
|
For
the nine months ended September 30, |
|
| |
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
| Research and development |
|
$ |
89,000 |
|
|
$ |
66,000 |
|
|
$ |
561,000 |
|
|
$ |
66,000 |
|
| General and administrative |
|
|
72,000 |
|
|
|
32,000 |
|
|
|
251,000 |
|
|
|
282,000 |
|
| Restricted stock-based compensation
expense included in operating expense |
|
|
161,000 |
|
|
|
98,000 |
|
|
|
812,000 |
|
|
|
348,000 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total restricted stock-based compensation
expense |
|
|
161,000 |
|
|
|
98,000 |
|
|
|
812,000 |
|
|
|
348,000 |
|
| Tax benefit |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Restricted stock-based
compensation expense, net of tax |
|
$ |
161,000 |
|
|
$ |
98,000 |
|
|
$ |
812,000 |
|
|
$ |
348,000 |
|
|